Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19

BACKGROUND: Given the importance of neutralising antibodies in protection against SARS-CoV-2 infection, it is critical to assess neutralisation persistence long-term following recovery. This study investigated neutralisation titres against SARS-CoV-2 up to 6 months post-symptom onset in individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Underwood, Alexander P., Sølund, Christina, Fernandez-Antunez, Carlota, Villadsen, Signe Lysemose, Winckelmann, Anni Assing, Bollerup, Signe, Mikkelsen, Lotte S., Sørensen, Anna-Louise, Feng, Shan, Fahnøe, Ulrik, Lassauniere, Ria, Fomsgaard, Anders, Ramirez, Santseharay, Weis, Nina, Bukh, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375401/
https://www.ncbi.nlm.nih.gov/pubmed/34419923
http://dx.doi.org/10.1016/j.ebiom.2021.103519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375401/
https://www.ncbi.nlm.nih.gov/pubmed/34419923
http://dx.doi.org/10.1016/j.ebiom.2021.103519

Ejemplares similares